Your browser doesn't support javascript.
loading
Decreasing delivery room CPAP-associated pneumothorax at ≥35-week gestational age.
Stocks, Edward F; Jaleel, Mambarambath; Smithhart, William; Burchfield, Patti J; Thomas, Anita; Mangona, Kate Louise M; Kapadia, Vishal; Wyckoff, Myra; Kakkilaya, Venkatakrishna; Brenan, Shelby; Brown, L Steven; Clark, Christopher; Nelson, David B; Brion, Luc P.
Afiliação
  • Stocks EF; University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Jaleel M; Oklahoma University, Norman, OK, USA.
  • Smithhart W; University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Burchfield PJ; University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Thomas A; Newborn Associates, Jackson, MO, USA.
  • Mangona KLM; University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Kapadia V; University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Wyckoff M; University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Kakkilaya V; University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Brenan S; University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Brown LS; University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Clark C; University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Nelson DB; Pediatrix, Colorado Springs, CO, USA.
  • Brion LP; Parkland Health & Hospital System, Dallas, TX, USA.
J Perinatol ; 42(6): 761-768, 2022 06.
Article em En | MEDLINE | ID: mdl-35173286
ABSTRACT

OBJECTIVE:

We previously reported an increase in pneumothorax after implementing delivery room (DR) continuous positive airway pressure (CPAP) for labored breathing or persistent cyanosis in ≥35-week gestational age (GA) neonates unexposed to DR-positive pressure ventilation (DR-PPV). We hypothesized that pneumothorax would decrease after de-implementing DR-CPAP in those unexposed to DR-PPV or DR-O2 supplementation (DR-PPV/O2). STUDY

DESIGN:

In a retrospective cohort excluding DR-PPV the primary outcome was DR-CPAP-related pneumothorax (1st chest radiogram, 1st day of life). In a subgroup treated by the resuscitation team and admitted to the NICU, the primary outcome was DR-CPAP-associated pneumothorax (1st radiogram, no prior PPV) without DR-PPV/O2.

RESULTS:

In the full cohort, occurrence of DR-CPAP-related pneumothorax decreased after the intervention (11.0% vs 6.0%, P < 0.001). In the subgroup, occurrence of DR-CPAP-associated pneumothorax decreased after the intervention (1.4% vs. 0.06%, P < 0.001).

CONCLUSION:

The occurrence of CPAP-associated pneumothorax decreased after avoiding DR-CPAP in ≥35-week GA neonates without DR-PPV/O2.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumotórax / Síndrome do Desconforto Respiratório do Recém-Nascido Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Female / Humans / Newborn / Pregnancy Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumotórax / Síndrome do Desconforto Respiratório do Recém-Nascido Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Female / Humans / Newborn / Pregnancy Idioma: En Ano de publicação: 2022 Tipo de documento: Article